companydata.dkONCONOX ApS: Financial statements 2016
CVR: 33858965
ONCONOX ApS (CVR 33858965) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 0 and a net result of DKK -14,568 compared with DKK 1,450,157 the year before. Equity amounted to DKK 995,496. The solvency ratio was 98.1%.
- Gross Profit
- 0 kr.
- Profit/Loss
- -14,568 kr.
- Equity
- 995,496 kr.
- Total Assets
- 1,014,657 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 0 | -15 t. | 995 t. | - |
| 2015 | - | - | 1.5 mio. | 1 mio. | - |
| 2014 | - | - | -50 t. | -93 | - |
| 2013 | - | - | -191 t. | 50 t. | - |
| 2012 | - | -705 t. | -712 t. | 240 t. | - |
How creditworthy is ONCONOX ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2016
ONCONOX ApS has published its annual report for 2015. The net result was DKK 1,450,157.
About ONCONOX ApS
ONCONOX ApS was a Danish company of the type Anpartsselskab based in Greve, founded in 2011. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company is owned by Amme Pharmaceuticals, Inc.. The company has 0 employees. In 2022, the company reported a net result of DKK -40,672 compared with DKK -43,846 the year before. Equity amounted to DKK -4,305.